Today, Zacks Rank #1 (Strong Buy) List has been updated, adding five stocks that promise growth for investors:
Inhibikase Therapeutics, Inc. IKT: This pharmaceutical company has witnessed a 16% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days.
Equitrans Midstream Corporation ETRN: This midstream energy company has observed an 11.7% surge in the Zacks Consensus Estimate for its current year earnings over the last 60 days.
ADMA Biologics, Inc. ADMA: This biopharmaceutical company has experienced a remarkable 33.3% rise in the Zacks Consensus Estimate for its current year earnings over the last 60 days.
Affirm Holdings, Inc. AFRM: This e-commerce company has seen its Zacks Consensus Estimate for current year earnings shoot up by 28.3% over the last 60 days.
Orchid Island Capital, Inc. ORC: This finance company has enjoyed a staggering 73.7% surge in the Zacks Consensus Estimate for its current year earnings over the last 60 days.
If you’re seeking more, here’s the full selection of today’s Zacks #1 Rank (Strong Buy) stocks.
Zacks Names #1 Semiconductor Stock
It’s only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.
With strong earnings growth and an expanding customer base, it’s positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.
See This Stock Now for Free >>
Orchid Island Capital, Inc. (ORC) : Free Stock Analysis Report
ADMA Biologics Inc (ADMA) : Free Stock Analysis Report
Equitrans Midstream Corporation (ETRN) : Free Stock Analysis Report
Inhibikase Therapeutics, Inc. (IKT) : Free Stock Analysis Report
Affirm Holdings, Inc. (AFRM) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
